AAAAAA

   
Results: 1-7 |
Results: 7
IN-VITRO ACTIVITY OF LY333328 AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI, METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, AND PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE
Authors: PATEL R ROUSE MS PIPER KE COCKERILL FR STECKELBERG JM
Citation: R. Patel et al., IN-VITRO ACTIVITY OF LY333328 AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI, METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS, AND PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 30(2), 1998, pp. 89-92
DETERMINATION OF 16S RIBOSOMAL-RNA SEQUENCES OF ENTEROCOCCI AND APPLICATION TO SPECIES IDENTIFICATION OF NONMOTILE ENTEROCOCCUS-GALLINARUM ISOLATES
Authors: PATEL R PIPER KE ROUSE MS STECKELBERG JM UHL JR KOHNER P HOPKINS MK COCKERILL FR KLINE BC
Citation: R. Patel et al., DETERMINATION OF 16S RIBOSOMAL-RNA SEQUENCES OF ENTEROCOCCI AND APPLICATION TO SPECIES IDENTIFICATION OF NONMOTILE ENTEROCOCCUS-GALLINARUM ISOLATES, Journal of clinical microbiology (Print), 36(11), 1998, pp. 3399-3407
EFFICACY OF AZITHROMYCIN OR CLARITHROMYCIN FOR PROPHYLAXIS OF VIRIDANS GROUP STREPTOCOCCUS EXPERIMENTAL ENDOCARDITIS
Authors: ROUSE MS STECKELBERG JM BRANDT CM PATEL R MIRO JM WILSON WR
Citation: Ms. Rouse et al., EFFICACY OF AZITHROMYCIN OR CLARITHROMYCIN FOR PROPHYLAXIS OF VIRIDANS GROUP STREPTOCOCCUS EXPERIMENTAL ENDOCARDITIS, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1673-1676
EFFECT OF GENTAMICIN DOSING INTERVAL ON EFFICACY OF PENICILLIN OR CEFTRIAXONE TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO PENICILLIN-SUSCEPTIBLE, CEFTRIAXONE-TOLERANT VIRIDANS GROUP STREPTOCOCCI
Authors: BRANDT CM WARNER CB ROUSE MS STECKELBERG JM WILSON WR
Citation: Cm. Brandt et al., EFFECT OF GENTAMICIN DOSING INTERVAL ON EFFICACY OF PENICILLIN OR CEFTRIAXONE TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO PENICILLIN-SUSCEPTIBLE, CEFTRIAXONE-TOLERANT VIRIDANS GROUP STREPTOCOCCI, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2901-2903
EFFECTIVE TREATMENT OF MULTIDRUG-RESISTANT ENTEROCOCCAL EXPERIMENTAL ENDOCARDITIS WITH COMBINATIONS OF CELL WALL-ACTIVE AGENTS
Authors: BRANDT CM ROUSE MS LAUE NW STRATTON CW WILSON WR STECKELBERG JM
Citation: Cm. Brandt et al., EFFECTIVE TREATMENT OF MULTIDRUG-RESISTANT ENTEROCOCCAL EXPERIMENTAL ENDOCARDITIS WITH COMBINATIONS OF CELL WALL-ACTIVE AGENTS, The Journal of infectious diseases, 173(4), 1996, pp. 909-913
EFFECTIVE TREATMENT OF CEPHALOSPORIN-RIFAMPIN COMBINATIONS AGAINST CRYPTIC METHICILLIN-RESISTANT BETA-LACTAMASE-PRODUCING COAGULASE-NEGATIVE STAPHYLOCOCCAL EXPERIMENTAL ENDOCARDITIS
Authors: BRANDT CM ROUSE MS TALLAN BM LAUE NW WILSON WR STECKELBERG JM
Citation: Cm. Brandt et al., EFFECTIVE TREATMENT OF CEPHALOSPORIN-RIFAMPIN COMBINATIONS AGAINST CRYPTIC METHICILLIN-RESISTANT BETA-LACTAMASE-PRODUCING COAGULASE-NEGATIVE STAPHYLOCOCCAL EXPERIMENTAL ENDOCARDITIS, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1815-1819
FAILURE OF TIME-KILL SYNERGY STUDIES USING SUBINHIBITORY ANTIMICROBIAL CONCENTRATIONS TO PREDICT IN-VIVO ANTAGONISM OF CEPHALOSPORIN-RIFAMPIN COMBINATIONS AGAINST STAPHYLOCOCCUS-AUREUS
Authors: BRANDT CM ROUSE MS TALLAN BM WILSON WR STECKELBERG JM
Citation: Cm. Brandt et al., FAILURE OF TIME-KILL SYNERGY STUDIES USING SUBINHIBITORY ANTIMICROBIAL CONCENTRATIONS TO PREDICT IN-VIVO ANTAGONISM OF CEPHALOSPORIN-RIFAMPIN COMBINATIONS AGAINST STAPHYLOCOCCUS-AUREUS, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2191-2193
Risultati: 1-7 |